Merck & Co., (MRK) Financials
Merck & Co., (MRK) Historical Financial Statements and Key Metrics for 1994 - 2025
Full Merck & Co., financials for 1994 - 2025 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Merck & Co., Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2025-Mar-31 | 15,529 | 12,110 (78.0 %) | 5,937 (38.2 %) | 5,079 (32.7 %) | 7,315 | 2.01 |
| 2024-Dec-31 | 15,624 | 14,700 (94.1 %) | 6,820 (43.7 %) | 3,743 (24.0 %) | 6,929 | 1.49 |
| 2024-Sep-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2024-Jun-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2024-Mar-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2023-Dec-31 | 14,630 | 11,290 (77.2 %) | -299 (-2.0 %) | -1,226 (-8.4 %) | 679 | -0.48 |
| 2023-Sep-30 | 15,962 | 11,698 (73.3 %) | 5,998 (37.6 %) | 4,745 (29.7 %) | 5,998 | 1.86 |
Full historical income statements for 1994 - 2025 is included in the
US Historical Financials dataset.
Merck & Co., Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2025-Mar-31 | 115,122 | 66,722 | 34,844 | 48,335 | 9,228 |
| 2024-Dec-31 | 117,106 | 70,734 | 37,111 | 46,313 | 13,689 |
| 2024-Sep-30 | 117,532 | 72,972 | 38,131 | 44,502 | 14,593 |
| 2024-Jun-30 | 112,630 | 68,982 | 37,788 | 43,582 | 11,396 |
| 2024-Mar-31 | 105,849 | 65,425 | 34,219 | 40,364 | 5,711 |
| 2023-Dec-31 | 106,675 | 69,040 | 36,268 | 37,581 | 7,161 |
| 2023-Sep-30 | 106,727 | 65,427 | 34,859 | 41,246 | 8,773 |
Full historical balance sheet data for 1994 - 2025 is included in the
US Historical Financials dataset.
Merck & Co., Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2025-Mar-31 | 2,500 | -1,487 | -5,755 | 1,172 |
| 2024-Dec-31 | 3,450 | -1,444 | -3,009 | 2,513 |
| 2024-Sep-30 | 9,291 | -3,845 | -2,425 | 8,508 |
| 2024-Jun-30 | 5,637 | -1,069 | 1,216 | 4,846 |
| 2024-Mar-31 | 3,090 | -1,376 | -2,814 | 2,229 |
| 2023-Dec-31 | 246 | 53 | -2,245 | -743 |
| 2023-Sep-30 | 7,717 | -334 | -4,269 | 6,815 |
Full historical cash flow data for 1994 - 2025 is included in the
US Historical Financials dataset.
Merck & Co., Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2025-Mar-31 | 227,183 | 253,398 | 14.63 | 11.18 | 4.70 |
| 2024-Dec-31 | 252,779 | 276,648 | 16.18 | 16.88 | 5.46 |
| 2024-Sep-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2024-Jun-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2024-Mar-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2023-Dec-31 | 276,148 | 305,507 | 18.88 | -56.31 | 7.35 |
| 2023-Sep-30 | 261,238 | 287,492 | 16.37 | 13.76 | 6.33 |
Full historical valuation and operating metrics for 1994 - 2025 are included in the
US Historical Financials dataset.